Chris Degnan

Business address
C/O Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester, PA, 19380
Top holdings (ownership)
URGN and GRTX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Chris Degnan has filed 13 SEC EDGAR filings since 14 Jun 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 09 Oct 2025 08 Oct 2025 001-38079
4 Open Document Open Filing 09 Oct 2024 08 Oct 2024 001-38079
3 Open Document Open Filing 09 Oct 2024 08 Oct 2024 001-38079
4 Open Document Open Filing FORM 4 SUBMISSION 14 Mar 2023 13 Mar 2023 001-39114
4 Open Document Open Filing FORM 4 SUBMISSION 28 Feb 2023 25 Feb 2023 001-39114
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2022 28 Feb 2022 001-39114
4 Open Document Open Filing FORM 4 SUBMISSION 28 Jan 2021 26 Jan 2021 001-39114
4 Open Document Open Filing FORM 4 SUBMISSION 04 Feb 2020 31 Jan 2020 001-39114
4 Open Document Open Filing FORM 4 SUBMISSION 08 Nov 2019 06 Nov 2019 001-39114
3 Open Document Open Filing FORM 3 SUBMISSION 06 Nov 2019 06 Nov 2019 001-39114
4 Open Document Open Filing FORM 4 SUBMISSION 04 Mar 2019 28 Feb 2019 001-38529
4 Open Document Open Filing FORM 4 SUBMISSION 15 Aug 2018 19 Jun 2018 001-38529
3 Open Document Open Filing FORM 3 SUBMISSION 14 Jun 2018 14 Jun 2018 001-38529